Predictive value of SRC-1 for tamoxifen response of recurrent breast cancer

Breast Cancer Research and Treatment

Volumn 48, Issue 1, 1998, Pages 87-92

  Berns, Els M J J ^a   Van Staveren, Iris L ^a   Klijn, Jan G M ^a   Foekens, John A ^a  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

Author keywords

Breast cancer; Response; RT PCR; SRC 1; Tamoxifen

Indexed keywords

ANTIESTROGEN; ESTROGEN RECEPTOR; STEROID RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; TAMOXIFEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST; BREAST CANCER; CANCER CELL CULTURE; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; FEMALE; HISTONE ACETYLTRANSFERASES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RECEPTORS, STEROID; TAMOXIFEN; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0031906362     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005903226483     Document Type: Article

References (17)

1. Katzenellenbogen BS, Montano MM, Ekena K, Herman ME, McInerney EM: Antiestrogens: Mechanisms of action and resistance in breast cancer. Breast Cancer Res Treat 44: 23-38, 1997
2. Klijn JGM, Berns EMJJ, Bontenbal M, Foekens JA: Cell biological factors associated with the response of breast cancer to systemic treatment. Cancer Treat Rev 19: 45-63, 1993
3. Klijn JGM, Berns EMJJ, Foekens JA: Prognostic factors and response to therapy in breast cancer. Cancer Surv 18: 165-198, 1993
4. Foekens JA, Look MP, Peters HA, van Putten WIJ, Portengen H, Klijn JGM: Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 predict poor response to tamoxifen therapy in recurrent breast cancer. J Natl Cancer Inst 87: 751-756, 1995
5. Beato M, Sanchez-Pacheco A: Interaction of steroid hormone receptors with the transcription initiation complex. Endocrine Rev 17: 587-609, 1996
6. Oñate SA, Tsai SY, Tsai MJ, O'Malley BW: Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270: 1354-1337, 1995
7. Ravdin PM, Green S, Dorr TM: Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: Results of a prospective Southwest Oncology Group study. J Clin Oncol 10: 1284-1291, 1992
8. Foekens JA, Portengen H, Look MP, van Putten WLJ, Thirion B, Bontenbal M, Klijn JGM: Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer. Br J Cancer 70: 1217-1223, 1994
9. Foekens JA, Portengen H, van Putten WLJ, Peters HAM, Krijnen E, Alexieva-Figusch J, Klijn JGM: Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast cancer. Cancer Res 49: 5823-5828, 1989
10. van Roozendaal KEP, Klijn JGM, van Ooijen B, Claassen C. Eggermont AMM, Henzen-Logmans SC, Foekens JA: Differential regulation of breast tumor cell proliferation by stromal fibroblasts of various breast tissue sources. Int J Cancer 65: 120-125, 1996
11. Gibbs RA, Nguyen PN, McBride LJ, Koepf SM, Caskey T: Identification of mutations leading to the Lesch-Nyhan syndrome by automated direct DNA sequencing of in vitro amplified cDNA. Proc Natl Acad Sci USA 86: 1919-1923, 1989
12. Heery DM, Kalkhoven E, Hoare S, Parker MG: A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387: 733-736, 1997
13. Smith CL, Nawaz Z, O'Malley BW: Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endo 11: 657-666, 1997
14. McInerney EM, Tsai MJ, O'Malley BW, Katzenellenbogen BS: Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. Proc Natl Acad Sci USA 93: 10069-10073, 1996
15. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG: A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403-414, 1996
16. Smith CL, Oñate SA, Tsai MJ, O'Malley BW: CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc Natl Acad Sci USA 93: 8884-8888, 1996
17. Yao TP, Ku G, Zhou N, Scully R, Livingston DM: The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc Natl Acad Sci USA 93: 10626-10631, 1996